dihydroxyphenylalanine has been researched along with Malignant Hypertension in 3 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ARNOLD, OH | 1 |
| CANNON, PJ | 1 |
| WHITLOCK, RT | 1 |
| MORRIS, RC | 1 |
| ANGERS, M | 1 |
| LARAGH, JH | 1 |
| Bock, KD | 1 |
3 other studies available for dihydroxyphenylalanine and Malignant Hypertension
| Article | Year |
|---|---|
[The therapy fo malignant hypertension].
Topics: Dihydroxyphenylalanine; Hypertension; Hypertension, Malignant | 1962 |
Effect of alpha-methyl DOPA in severe and malignant hypertension.
Topics: Dihydroxyphenylalanine; Hypertension; Hypertension, Malignant; Methyldopa | 1962 |
[Conservative treatment of hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aniline Compounds; Dihydroxyphenylalanine; Female; Guaneth | 1970 |